Диссертация (1174323), страница 21
Текст из файла (страница 21)
Steril. 2016.Т. 106. № 2. С. 342–347.e2.101. Goswamy R.K., Williams G., Steptoe P.C. Decreased uterine perfusion--acause of infertility. // Hum. Reprod. 1988. Т. 3. № 8. С. 955–9.102. Gougeon A. Regulation of ovarian follicular development in primates: Factsand hypotheses // Endocr. Rev. 1996. Т. 17.
№ 2. С. 121–155.103. Greene A.D., Patounakis G., Segars J.H. Genetic associations with diminishedovarian reserve: A systematic review of the literature // J. Assist. Reprod. Genet.2014. Т. 31. № 8. С. 935–946.104. Griesinger G. и др. GnRH-antagonists in ovarian stimulation for IVF inpatients with poor response to gonadotrophins, polycystic ovary syndrome, andrisk of ovarian hyperstimulation: a meta-analysis // Reprod. Biomed. Online.2006. Т.
13. № 5. С. 628–638.126105. Haadsma M.L. и др. The number of small antral follicles (2-6 mm) determinesthe outcome of endocrine ovarian reserve tests in a subfertile population // Hum.Reprod. 2007. Т. 22. № 7. С. 1925–1931.106. Haadsma M.L. и др. The predictive value of ovarian reserve tests formiscarriage in a population of subfertile ovulatory women // Hum. Reprod. 2009.Т. 24. № 3.
С. 546–552.107. Haahr T, Esteves SC, Humaidan P. Poor definition of poor-ovarian responseresults in misleading clinical recommendations. Hum Reprod. (2018) 33:979–80.10.1093/humrep/dey059108. Hall J.E., Welt C.K., Cramer D.W. Inhibin A and inhibin B reflect ovarianfunction in assisted reproduction but are less useful at predicting outcome. // Hum.Reprod.
1999. Т. 14. № 2. С. 409–15.109. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygenspecies (ROS) generated by mitochondrial P450 systems in steroidogenic cells.Drug. Metab. Rev. 2006; 38: 171-96 DOI: 10.1080/03602530600570040110. Hunter R.H.F. (ed.). Physiology of the Graafian Follicle and Ovulation.Cambridge, UK: Cambridge University Press; 2003.111. Hauzman E.E.
и др. Cycle scheduling for in vitro fertilization with oralcontraceptive pills versus oral estradiol valerate: A randomized, controlled trial //Reprod. Biol. Endocrinol. 2013. Т. 11. № 1.112. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a morediscriminatory marker of assisted reproductive technology outcome thanfolliclestimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82:5:13231329.113. Hendriks D.
Ultrasonography as a tool for the prediction of outcome in IVFpatients: a comparative meta-analysis of ovarian volume and antral follicle count.// Fertil Steril. 2007. Т. 87. № 4. С. 764–75.114. HS Koo. Serial Evaluation of Endometrial Blood Flow for Prediction ofPregnancyOutcomesinPatientsWhoUnderwentControlledOvarian127Hyperstimulation and In Vitro Fertilization and Embryo Transfer.
// J UltrasoundMed. 2017. Т. Oct 9.115. Humaidan P. и др. The novel POSEIDON stratification of ‘Low prognosispatients in Assisted Reproductive Technology’ and its proposed marker ofsuccessful outcome // F1000Research. 2016. Т. 5. № 0. С. 2911.116. Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J,Schertz J, ESPART Study Investigators /Efficacy and safety of follitropinalfa/lutropin alfa in ART: a randomized controlled trial in poor ovarianresponders.// Hum Reprod.
2017 Mar 1; 32(3):544-555.117. Hussain M. и др. Discrepancies between Antimullerian Hormone and FollicleStimulating Hormone in Assisted Reproduction // Obstet. Gynecol. Int. 2013. Т.2013. С. 1–6.118. Ferraretti A.P. ESHRE consensus on definition of “poor response” to ovarianstimulation for in vitro fertilization: the Bologna criteria./Ferraretti A.P., La MarcaA., Fauser B.C. et al.//Hum. Reprod. 2011.
Vol. 26. № 7. Р. 1616 1624.119. Ibrahim A. The Minimal Stimulation Protocol for ICSI: An AlternativeProtocol for Ovarian Stimulation. // N Y Sci J. 2014. Т. 7. С. 19–23.120. Ivanovski M. Assessment of uterine artery and arcuate artery blood flow bytransvaginal color Doppler ultrasound on the day of human chorionicgonadotropin administration as predictors of pregnancy in an in vitro fertilizationprogram.
// Akush Ginekol (Sofiia). 2012. Т. 51. № 2. С. 55–60.121. Jain T., Soules M.R., Collins J.A. Comparison of basal follicle-stimulatinghormone versus the clomiphene citrate challenge test for ovarian reserve screening// Fertil. Steril. 2004. Т. 82. № 1. С. 180–185.122. Jancar N., Virant-Klun I., Osredkar J., Vrtacnik Bokal E. Apoptosis, reactiveoxygen species and follicular anti-Müllerian hormone in natural versus stimulatedcycles.
Reprod. Biomed. Online. 2008; 16: 640-8.123. Jayaprakasan K. и др. Does 3D ultrasound offer any advantage in thepretreatment assessment of ovarian reserve and prediction of outcome after128assisted reproduction treatment? // Hum. Reprod. 2007. Т. 22. № 7. С. 1932–1941.124. Jayaprakasan K.
и др. The three-dimensional ultrasonographic ovarianvascularity of women developing poor ovarian response during assistedreproduction treatment and its predictive value // Fertil. Steril. 2009. Т. 92. № 6.С. 1862–1869.125. Jeve Y. Effective treatment protocol for poor ovarian response: A systematicreview and meta-analysis // J Hum Reprod Sci. 2016. Т. 9. № 2. С. 70–81.126. Jianing Wang, Fei Xia, Ying Zhou, Xuedong Wei, Yanyan Zhuang, YingxueHuang M Association Between Endometrial/Subendometrial Vasculature andEmbryo Transfer Outcome: A Meta-analysis and Subgroup Analysis. J UltrasoundMed.
2018 Jan;37(1):149-163. doi: 10.1002/jum.14319. Epub 2017 Jul 17.127. Jirge P. Ovarian reserve tests // J. Hum. Reprod. Sci. 2011. Т. 4. № 3. С. 108.128. Jirge P. Poor ovarian reserve // J. Hum. Reprod. Sci. 2016. Т. 9. № 2. С. 63.129. Kalmantis K, Loutradis D, Lymperopoulos E, Beretsos P, Bletsa R, AntsaklisA.
Three Dimensional Power Doppler evaluation of human endometrium afteradministration of oxytocine receptor antagonist ( OTRa ) in an IVF program.,Arch Gynecol Obstet. 2012 Jan;285(1):265-70. doi: 10.1007/s00404-011-2019-2.Epub 2011 Aug 7.130. Kamble L., Gudi A., Sha A., Homburg R. Poor responders to controlledovarian hyperstimulation for in vitro fertilisation (IVF). Hum. Fertil. 2011; 14(4):230-45.131. Karlstrom P.O., Rodriques-Wallberg K.A. Stimulation with hMG results inhigher live birth and ongoing pregnancy rates than rFSH in IVF/ICSI patientsrequiring with high doses of gonadotropins./Karlstrom P.O.//Hum. Reprod.
2012.-Vol. 27. Suppl. 1: Abstract Book. -P-286. i.227-228.132. Kar S. Current evidence supporting «letrozole» for ovulation induction // J.Hum. Reprod. Sci. 2013. Т. 6. № 2. С. 93129133. Kasius A., Smit J. G., Torrance H. L. et al. Endometrial thickness andpregnancy rates after IVF: a systematic review and meta-analysis. Hum. Reprod.Updatе.
2014; 20 (4): 530–541.134. Katz-Jaffe M.G. и др. Association of abnormal ovarian reserve parameterswith a higher incidence of aneuploid blastocysts // Obstet. Gynecol. 2013. Т. 121.№ 1. С. 71–77.135. Karuputhula N.B., Chattopadhyay R., Chakravarty B., Chaudhury K. Oxidativestatus in granulosa cells of infertile women undergoing IVF. Syst.
Biol. Reprod.Med. 2013; 59: 91-8 DOI: 10.3109/19396368.2012.743197136. Keane K, Cruzat VF, Wagle S, Chaudhary N, Newsholme P, Yovich J./Specific ranges of anti-Mullerian hormone and antral follicle count correlate toprovide a prognostic indicator for IVF outcome.// Reprod Biol.
2017 Mar;17(1):51-59. Epub 2017 Jan 26.137. Kim A. и др. Detection of endometrial and subendometrial vasculature on theday of embryo transfer and prediction of pregnancy during fresh invitrofertilization cycles // Taiwan. J. Obstet. Gynecol. 2014. Т. 53. № 3. С. 360–365.138. Kim S.H. и др.
Clinical significance of transvaginal color Dopplerultrasonography of the ovarian artery as a predictor of ovarian response incontrolled ovarian hyperstimulation for in vitro fertilization and embryo transfer //J. Assist. Reprod. Genet. 2002. Т. 19. № 3. С. 103–112.139. Kwee J. и др. Intercycle variability of ovarian reserve tests: results of aprospective randomized study. // Hum. Reprod.
2004. Т. 19. № 3. С. 590–5.140. Kwee J. и др. Ovarian volume and antral follicle count for the prediction oflow and hyper responders with in vitro fertilization. // Reprod. Biol. Endocrinol.2007. Т. 5. С. 9.141. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Carducci A,Artenisio, Stabile G, Volpe A. Anti-Müllerian hormone (AMH) as a predictivemarker in assisted reproductive technology (ART).
Hum Reprod. 2010;16:2:113130. .https://doi.org/10.1093/humupd/dmp036130142. Lampiao F. Free radicals generation in an in vitro fertilization setting and howto minimize them // World J. Obstet. Gynecol. 2012. Т. 1. № 3. С. 29.143. Lass A., Brinsden P. The role of ovarian volume in reproductive medicine //Hum. Reprod. Update. 1999. Т. 5. № 3.
С. 256–266.144. Leao R., Esteves S. Gonadotropin therapy in assisted reproduction: anevolutionary perspective from biologics to biotech // Clinics. 2014. Т. 69. № 4. С.279–293.145. Lecce G., Meduri G., Ancelin M. Presence of estrogen recep- tor bin thehuman endometrium through the cycle: expres- sion inglandular, stromal, andvascular cells // J. Clin. Endo- crinol. Metab.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
